In the Open Study, which put 160 cases of
COPD patients into Mucodyne administration group and control group, Mucodyne proved effective with drastically reduced occurrence of chronic disease in the Mucodyne administered patients.
Results show Australian mortality rates in people with IHD, CVD, RHD, and
COPD have fallen over the past 25 years but death rates for all six diseases have increased in NT Indigenous people compared to the non-Indigenous population.
Ambient pollution had opposing effects on HRV in our
COPD and MI participants, resulting in no significant effect of ambient pollution on HRV in the entire population for 1-, 4-, or 24-hr moving averages.
